Investor Ideas, Trading Ideas and Stocks to Watch

Thursday, September 10, 2020

#ExploringMining #Podcast Episode 100 – #Mining #Stocks News from (TSXV: $BRG.V) (B7LM.F) (NYSE: $RIO) (NYSE: $TRQ) (TSXV: $PEMC.V) (TSXV: $BLUE.V)

#ExploringMining #Podcast Episode 100 – #Mining #Stocks News from (TSXV: $BRG.V) (B7LM.F) (NYSE: $RIO) (NYSE: $TRQ) (TSXV: $PEMC.V) (TSXV: $BLUE.V)

Point Roberts WA, Delta BC, September 10, 2020 Investorideas.com, a global investor news source covering mining and metals stocks releases today’s edition of Exploring Mining Podcast, featuring stock news from TSX, TSXV ,CSE, ASX, NASDAQ, NYSE companies plus interviews with CEO's and leading experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/091020-Mining.mp3

Read this in full at https://www.investorideas.com/news/2020/exploring-mining/09101BRG-RIO-TRQ-PEMC-BLUE.asp

Listen to Exploring Mining podcast on iTunes Apple podcasts

Listen to Exploring Mining on Spotify

Brigadier Gold Limited (TSXV:BRG) (B7LM.F) has provided an update on its exploration programs planned for the Picachos and Killala Lake properties. Regarding the Picachos property, Brigadier President and CEO, Ranjeet Sundher, said:

“The Picachos property, an approximate two-hour drive from Mazatlán, has all permits in place and a recently renewed surface access agreement with the local community. The project has never been diamond drill tested and boasts over 160 historic workings and mines, which are accessible by more than 20 km of roads internal to the property.”

According to the press release, the company holds an option to acquire 100 percent of the Killala Lake South diamond property located in the Thunder Bay, Ontario mining district, and “is planning to initiate exploration in Q1-2021.”

Rio Tinto Group (NYSE:RIO) has entered into a memorandum of understanding (MOU) with Turquoise Hill Resources Ltd. (NYSE:TRQ) providing a funding plan for the completion of the Oyu Tolgoi Underground Project in Mongolia. Rio Tinto’s chief executive of Copper & Diamonds, Arnaud Soirat, said:

"The MOU agreed today with TRQ provides a clear funding pathway for the completion of the Oyu Tolgoi Underground Project. We will continue working with TRQ and the Government of Mongolia to progress the underground project, which has the potential to unlock the most valuable part of the mine for the benefit of all stakeholders."

Pacific Empire Minerals Corp. (TSXV:PEMC) has announced the start of reverse circulation drilling activities at the Weedon Property in central British Columbia, as well as completion of Phase 1 drilling at the Worldstock Property with assays expected in the coming weeks. Speaking on the company’s further plans for its Jean Marie property, a copper-gold-silver-molybdenum porphyry project in central British Columbia, CEO Brad Peters said:

"As we gear up to drill the Jean Marie property in the coming weeks, we are excited to test the highly compelling T1 target at Weedon. We expect to receive drill permits for Jean Marie in the coming weeks, and although Jean Marie will be our focus in 2020, Weedon remains untested with drilling, despite previous exploration programs by sophisticated groups. The Weedon Property demonstrates the potential to make a blind discovery in an easily-accessible area with robust existing infrastructure."

Blue Thunder Mining Inc. (TSXV:BLUE) has announced that it started diamond drilling on the Fancamp Gold Property over the past weekend. Robert Cinits, Blue Thunder’s President and CEO, commented:

"We are excited that diamond drilling has started at Fancamp for our inaugural, fully-funded drilling program. Fancamp is our first of many priority targets for drilling activities and the drilling is designed to not only substantiate selected historical results, but also to test projected extensions to the multiple mineralized veins and zones identified by historical exploration and uncovered during our recent trenching program."

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Research mining stocks at Investorideas.com with our mining stocks directory at Investorideas.com https://www.investorideas.com/Gold_Stocks/Stocks_List.asp

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com to be a guest or sponsor this podcast

800-665-0411

Get more mining stock investor ideas- news, articles, podcasts and stock directories

#Coronavirus /#Biotechnology (#COVID19) #Stock News Bites-Reign Resources Corporation (OTCMARKETS: $RGNP) Approves Sigyn Therapeutics Merger- CEO of Sigyn former CEO of Aethlon Medical (NASDAQ: $AEMD)

#Coronavirus /#Biotechnology (#COVID19) #Stock News Bites-Reign Resources Corporation (OTCMARKETS: $RGNP) Approves Sigyn Therapeutics Merger- CEO of Sigyn former CEO of Aethlon Medical (NASDAQ: $AEMD)

New Medical technology company focused on the treatment of life-threatening inflammatory conditions

Investorideas.com (www.investorideas.com) Coronavirus /Biotechnology (COVID-19) Stock News Bites - Reign Resources Corporation (“Reign”) (OTCMARKETS: RGNP) announced today that the Company has approved a share exchange agreement with Sigyn Therapeutics, Inc., a privately held medical technology company focused on the treatment of life-threatening inflammatory conditions. As reported in a Schedule 14C Information statement filed today with the U.S. Securities and Exchange Commission (SEC) and a Form 8-K filed on August 31, 2020, Reign resources will acquire all of the outstanding capital stock of Sigyn Therapeutics in exchange for shares of Reign common stock representing approximately 75 percent of Reign’s outstanding common stock. The Schedule 14C Information statement and Form 8-K can be accessed at www.SEC.gov.

Upon completion of the merger, Reign will be renamed Sigyn Therapeutics, Inc. and will be led by Sigyn co-founder Jim Joyce, who will serve as Chairman and CEO of the combined company. Sigyn Therapeutics will be focused on addressing a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome (“The Cytokine Storm” or “CSS”) and not addressed with an approved therapy. The annual market opportunity for a therapeutic strategy to prevent or mitigate CSS has been reported to exceed $20 billion. Additional announcements regarding the combined company’s management structure, Board of Directors and Science Advisory Board will be forthcoming.

Sigyn Therapy™ is a development-stage blood purification technology designed to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory conditions, including sepsis, which is the #1 cause of hospital deaths. The mechanism of Sigyn Therapy allows for a broad-spectrum of inflammatory targets to be depleted from the bloodstream. Among the targets are inflammatory cytokines, cytokine aggregates, endotoxin and CytoVesicles that transport cytokines and other inflammatory cargos.

Beyond sepsis, Cytokine Storm related therapeutic opportunities include, but are not limited to virus induced Cytokine Storm (a leading cause of COVID-19 deaths), bacteria induced Cytokine Storm, acute respiratory distress syndrome (ARDS) and acute forms of liver failure, including hepatic encephalopathy. Sigyn Therapy may also be a candidate to stabilize or extend the life of patients waiting for the identification of a matched liver for transplantation. In such a scenario, Sigyn Therapy™ would serve as a bridge-to-liver transplant. Cytokine Storm Syndrome can also result from trauma, severe burns, acute pancreatitis, adverse drug reactions, cancer immunotherapies, cancer cachexia, acute kidney injury (AKI) and severe pneumonia.

Other Corporate Highlights

· Sigyn’s co-founders have 50+ years of experience in the medical technology field and played instrumental roles in the development of three technologies that have been cleared by the FDA to treat COVID-19 infected individuals.

· Jim Joyce, the Chairman and CEO of Sigyn Therapeutics, has two decades of public company CEO and Board leadership experience. Specific to therapeutic blood purification, Mr. Joyce was the founder, Chairman and CEO of Aethlon Medical, ( NASDAQ: AEMD) a company that he navigated from a single shareholder start-up to Nasdaq-traded Company with 8,000+ shareholders.

· Sigyn Therapy aligns with U.S. government initiatives to support broad-spectrum treatment countermeasures that mitigate life-threatening conditions resulting from pandemic outbreaks such as COVID-19.

· A deep pipeline of pre-clinical, clinical and regulatory milestones are planned over the next 12-18 months.

Read the company’s full news and disclaimer here:

https://finance.yahoo.com/news/reign-resources-corporation-announces-approval-184400089.html

Visit Investorideas.com biotech and coronavirus stocks directory https://www.investorideas.com/BIS/stock_list.asp

Stock Bites is a branded product of Investorideas.com Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. This stock bites news release publication is available as a paid for service on Investorideas.com https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Download our Mobile App for iPhone and Android

Get free investor news alerts

https://www.investorideas.com/Resources/Newsletter.asp

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Breaking #Medical #Tech/ #Covid19 #Stock News - Reign Resources Corporation (OTCMARKETS: $RGNP) Announces Approval of Sigyn Therapeutics Merger

Breaking #Medical #Tech/ #Covid19 #Stock News - Reign Resources Corporation (OTCMARKETS: $RGNP) Announces Approval of Sigyn Therapeutics Merger

#Medicaltechnology company focused on the treatment of life-threatening inflammatory conditions

Jim Joyce, the Chairman and CEO of Sigyn Therapeutics (OTCMARKETS: $RGNP) was founder, Chairman and CEO of Aethlon Medical (NASDAQ: $AEMD)

LOS ANGELES, CA, September 10, 2020 (Investorideas.com newswire) Breaking Medical Tech/ Covid- 19 stock news - Reign Resources Corporation (“Reign”) (OTCMARKETS: RGNP) announced today that the Company has approved a share exchange agreement with Sigyn Therapeutics, Inc., a privately held medical technology company focused on the treatment of life-threatening inflammatory conditions. As reported in a Schedule 14C Information statement filed today with the U.S. Securities and Exchange Commission (SEC) and a Form 8-K filed on August 31, 2020, Reign resources will acquire all of the outstanding capital stock of Sigyn Therapeutics in exchange for shares of Reign common stock representing approximately 75 percent of Reign’s outstanding common stock. The Schedule 14C Information statement and Form 8-K can be accessed at www.SEC.gov.

Read this news, featuring RGNP in full at https://www.investorideas.com/news/2020/biotech/09101RGNP-Sigyn-Therapeutics-Merger.asp

Other Corporate Highlights

· A deep pipeline of pre-clinical, clinical and regulatory milestones are planned over the next 12-18 months.

About Sigyn Therapeutics

Sigyn Therapeutics is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives.

Sigyn Therapy™ is a patent pending blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the most common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a leading cause of SARS-CoV-2 (COVID-19) deaths. Other therapeutic opportunities include, but are not limited to bacteria induced cytokine storm (BICS), acute respiratory distress syndrome (ARDS) and acute forms of liver failure, such as hepatic encephalopathy.

To learn more, visit www.SigynTherapeutics.com or www.SigynTherapy.com

About Reign Resources Corporation

Reign Resources Corp. is a Los Angeles-based, gold exploration company with a specific focus on the Bendigo & Ballarat regions in Victoria, Australia.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements of Reign Resources Corporation. (“Reign”) that involve substantial risks and uncertainties. All statements contained in this press release are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The words “could,” “will,” “plan,” “intend,” “anticipate,” “approximate,” “expect,” “potential,” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among others, statements about Reign’s future financial performance, the impact of management changes, any proposed organizational restructuring, results of operations, capital resources to fund operations; statements about Reign’s expectations regarding the capitalization, resources and ownership structure of the combined company; statements about the potential benefits of the transaction; the expected completion and timing of the transaction and other information relating to the transaction; and any other statements other than statements of historical fact. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that Reign makes due to a number of important factors, including (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect Reign’s business and the price of the common stock of Reign, (ii) the failure to satisfy of the conditions to the consummation of the transaction, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (iv) risks related to the ability to realize the anticipated benefits of the transaction, including the risk that the businesses will not be integrated successfully, (v) the effect of the announcement or pendency of the transaction on Reign’s business relationships, operating results and business generally, (vi) risks that the proposed transaction disrupts current plans and operations, (vii) risks related to the combined entity’s ability to uplist to a national securities exchange, (viii) risks related to the combined entity’s access to existing capital and fundraising prospects to fund its ongoing operations, (ix) risks related to diverting management’s attention from Reign’s ongoing business operations, (x) other business effects, including the effects of industry, market, economic, political or regulatory conditions, future exchange and interest rates, and changes in tax and other laws, regulations, rates and policies, and (xi) the outcome of any legal proceedings that may be instituted against Reign related to the merger agreement or the transaction. Further risks that could cause actual results to differ materially from those matters expressed in or implied by such forward-looking statements are discussed in “Risk Factors” and elsewhere in Reign’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 and other reports filed with the SEC. The forward-looking statements in this press release represent Reign’s views as of the date of this press release. Reign anticipates that subsequent events and developments will cause its views to change. However, while it may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. You should, therefore, not rely on these forward-looking statements as representing Reign’s views as of any date subsequent to the date of this press release.

Contact Reign Resources Corporation

Joseph Segelman

CEO

(213) 457 3772

info@reignsc.com

Contact Sigyn Therapeutics, Inc.

Jim Joyce

Chairman, CEO

(619) 368-2000

jimjoyce@elevatescience.com

Investorideas.com Paid news Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: this news release featuring (OTCMARKETS: RGNP) is a paid for news release on Investorideas.com https://www.investorideas.com/News-Upload/ More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please Read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

https://www.investorideas.com/About/

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

BiotechIndustryStocks.com - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

Buy a biotech guest post on Investorideas.com

Wednesday, September 09, 2020

#AIEye Episode 428: AWS (NasdaqGS: $AMZN) and #NFL Debuting Six New Insights Through Next Gen Stats Platform, Schlumberger (NYSE: $SLB) Collaborating with IBM (NYSE: $IBM) and Red Hat on Oil & Gas Digital Transformation

#AIEye Episode 428: AWS (NasdaqGS: $AMZN) and #NFL Debuting Six New Insights Through Next Gen Stats Platform, Schlumberger (NYSE: $SLB) Collaborating with IBM (NYSE: $IBM) and Red Hat on Oil & Gas Digital Transformation

AI in Cybersecurity Market to Reach $101.8 Billion in 2030

Point Roberts WA, Vancouver BC – September 9, 2020 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2020/090920-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2020/artificial-intelligence/09091AIEye-AMZN-NFL-SLB-IBM.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:AMZN) (NYSE:IBM) (NYSE:SLB)

Amazon Web Service (AWS), a subsidiary of Amazon (NasdaqGS:AMZN) is debuting six new insights with the National Football League (NFL), through the latter’s Next Gen Stats Platform “during the September 10th season kickoff game between the Houston Texans and the Super Bowl Champion Kansas City Chiefs.” Matt Swensson, Vice President, Emerging Products and Technology at the NFL, said:

"This season’s Next Gen Stats powered by AWS represent the NFL’s continued investment in cloud technology to improve not only the fan experience for millions of people around the world, but also the way the game is played. Our partnership with AWS and the use of machine learning have enabled our fans to better understand the remarkable performance of the athletes on the field. They have also uncovered opportunities for NFL teams to use this data to improve their performance by breaking down the action in new ways and analyzing plays at a deeper level after the game."

IBM (NYSE:IBM), Red Hat, and Schlumberger (NYSE:SLB) are collaborating to accelerate digital transformation across the oil and gas industry. The collaboration will focus on hybrid cloud deployment of DELFI – Schlumberger's leading exploration and production (E&P) cloud-based environment and cognitive applications – which utilizes cutting-edge data analytics and artificial intelligence. IBM CEO Arvind Krishna said:

"The logic, purpose, and differentiation of all businesses can now be rendered in code, which is why digital innovation has become the most powerful way to drive transformation and hybrid cloud is the lever that unleashes it. Together with Schlumberger, we are empowering a much broader group of participants to play a role in driving that transformation and helping the energy industry solve some of the world's toughest challenges to emerge stronger."

AI in Cybersecurity Market to Reach $101.8 Billion in 2030

A report from Prescient & Strategic Intelligence finds that the global AI in Cybersecurity market will grow from $8.6 billion in 2019 to $101.8 billion in 2030 with a compound annual growth rate (CAGR) of 25.7 percent in the forecast period 2020-2030. An excerpt from the report description outlines the role of cyber crime in driving the market:

With the rising incidence of cybercrimes, artificial intelligence in cyber security is playing a vital role in combating such miscreants. Cyber frauds, such as identity and payment card thefts, account for over 55% of all cybercrimes, and they cause major losses to organizations, if not countered quickly. AI-driven solutions combat cyber fraud by identifying threats, reducing response time, and refining techniques to distinguish attacks that require immediate attention. In August 2019, the U.S. Government Accountability Office (GAO) stated that despite taking actions to combat cyber incidents, the cases are growing on a yearly basis. Such factors are boosting the growth of the AI in cyber security market.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

About Investorideas.com

About Investorideas.com - Big Investing Ideas Investorideas.com is a platform for investing ideas. We publish breaking stock news, stock research, guest posts and create original top rated investing podcasts, plus sector tag articles featuring up and coming companies and industry leaders. Investor Idea’s original branded content includes the Crypto Corner Podcast , Play by Play Sports Podcast , Cannabis News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast and the AI Eye Podcast. We also create free investor stock directories for AI and tech, biotech, cannabis, cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas, sports and water. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/disclosure

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas, Trading Ideas and Stocks to Watch

Thursday, September 10, 2020

#ExploringMining #Podcast Episode 100 – #Mining #Stocks News from (TSXV: $BRG.V) (B7LM.F) (NYSE: $RIO) (NYSE: $TRQ) (TSXV: $PEMC.V) (TSXV: $BLUE.V)

#Coronavirus /#Biotechnology (#COVID19) #Stock News Bites-Reign Resources Corporation (OTCMARKETS: $RGNP) Approves Sigyn Therapeutics Merger- CEO of Sigyn former CEO of Aethlon Medical (NASDAQ: $AEMD)

Breaking #Medical #Tech/ #Covid19 #Stock News - Reign Resources Corporation (OTCMARKETS: $RGNP) Announces Approval of Sigyn Therapeutics Merger

Wednesday, September 09, 2020

#AIEye Episode 428: AWS (NasdaqGS: $AMZN) and #NFL Debuting Six New Insights Through Next Gen Stats Platform, Schlumberger (NYSE: $SLB) Collaborating with IBM (NYSE: $IBM) and Red Hat on Oil & Gas Digital Transformation

Blog Archive

Links

Search This Blog